Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Octisalate is an organic compound used as a chemical sunscreen agent in over-the-counter sunscreens and cosmetic products. It is the ester of salicylic acid and 2-ethylhexanol. The primary mechanism of action involves the absorption of UVB radiation (wavelengths 295–315 nm), protecting skin from sunburn and other harmful effects of ultraviolet light exposure[1][3][6][8]. Octisalate forms a shielding film on the skin that absorbs UVB rays and converts them into less damaging energy[6]. It does not protect against UVA radiation and is typically combined with other sunscreen agents to provide broad-spectrum protection[1][3]. Octisalate also acts as an emollient due to its fatty alcohol component. The FDA has approved its use in sunscreens at concentrations up to 5%[4][5][6]. While generally considered safe with a good safety profile, there are some concerns about systemic absorption and potential endocrine disruption at high exposure levels[7][8]. Developed by Symrise.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on octisalate.